Investing.com - Quest Diagnostics reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $3.33 on revenue of $2.74B. Analysts polled by Investing.com anticipated EPS of $3.21 on revenue of $2.67B.
Quest Diagnostics shares are up 2% from the beginning of the year and are trading at $135.91 , down-from-52-week-high.They are outperforming the S&P 500 which is down 3.71% from the start of the year.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar